Fundraising Fox

Matthew Reber

Investor

Partner at 1315 Capital · Board director at Primrose Bio · Board director at Experic

About

Matthew Reber joined 1315 Capital as a Partner in 2017, having previously spent nine years at HealthCare Royalty Partners, where he was a Managing Director, along with earlier roles at Accretive LLC, Paul Capital Partners, Oak Hill Capital Partners, J.H. Whitney & Co., and Morgan Stanley. His investing work focuses on the pharma/medtech outsourcing and pharma/medtech product sectors. He holds a BSc in Engineering from Princeton University, an MBA from The Wharton School, and a Master of Biotechnology from the University of Pennsylvania.

Contact· self-published, not guessed

Invests in

BiotechHealthtechMedical Devices

Board director at Primrose Bio

Intro paths

In turn, Matthew can intro founders to Primrose Bio's investors below.

Board director at Experic

Intro paths

In turn, Matthew can intro founders to Experic's investors below.

Investments

Board seats

Coating PlaceCodisExpericMedivant HealthcarePrimrose BioProScientoReaction BiologySciSafeUSpharmaVerogen

Per the firm's website.

Colleagues at 1315 Capital

Frequently asked questions

Who is Matthew Reber?
Matthew Reber joined 1315 Capital as a Partner in 2017, having previously spent nine years at HealthCare Royalty Partners, where he was a Managing Director, along with earlier roles at Accretive LLC, Paul Capital Partners, Oak Hill Capital Partners, J.H. Whitney & Co., and Morgan Stanley. His investing work focuses on the pharma/medtech outsourcing and pharma/medtech product sectors. He holds a BSc in Engineering from Princeton University, an MBA from The Wharton School, and a Master of Biotechnology from the University of Pennsylvania.
Where does Matthew Reber work?
Matthew Reber is Partner at 1315 Capital and Board director at Primrose Bio and Board director at Experic.
What does Matthew Reber invest in?
Matthew Reber invests in Biotech, Healthtech, Medical Devices.
What boards does Matthew Reber sit on?
Matthew Reber holds tracked board seats at Coating Place, Codis, Experic, Medivant Healthcare, Primrose Bio, ProSciento, Reaction Biology, SciSafe, USpharma, Verogen.